HKU Scholars Hub: Browsing DSpace

Browsing by Author Kong, FE

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 5 of 5

	Title	Author(s)	Issue Date	Views
	A hepatocyte differentiation model reveals two subtypes of liver cancer with different oncofetal properties and therapeutic targets Journal:Proceedings of the National Academy of Sciences	Liu, M Yan, Q Sun, Y Nam, Y Hu, L Loong, JHC Ouyang, Q Zhang, Y Li, HL Kong, FE Li, L LI, Y Li, MM Cheng, W Jiang, LX Fang, S YANG, XD Mo, JQ Gong, YF Tang, YQ Li, Y Yuan, YF Ma, NF Lin, G Ma, S Wang, JG Guan, XY	2020	96
	Growth differentiation factor 1-induced tumour plasticity provides a therapeutic window for immunotherapy in hepatocellular carcinoma Journal:Nature Communications	Cheng, W Li, HL Xi, SY Zhang, XF Zhu, Y Le, X Mo, YX Li, MM Kong, FE Zhu, WJ Chen, XG Cui, HQ Cao, ZM Gong, YF Tang, YQ Zhang, Y Guan, X Ma, NF Liu, M	2021	12
	Identification of prognostic claudins signature in hepatocellular carcinoma from a hepatocyte differentiation model Journal:Hepatology International	Kong, FE Tang, YQ Gong, YF Mo, JQ Zhao, Y Li, MM Cheng, W Li, HL Zhu, WJ Liu, SS Huang, L Guan, XY Ma, NF Liu, M	2020	41
	PARP inhibitor Olaparib overcomes Sorafenib resistance through reshaping the pluripotent transcriptome in hepatocellular carcinoma Journal:Molecular Cancer	YANG, XD Kong, FE Qi, L Lin, JX Yan, Q Loong, JHC Xi, SY Zhao, Y Zhang, Y Yuan, YF Ma, NF Ma, S Guan, XY Liu, M	2021	74
	Targeting tumor lineage plasticity in hepatocellular carcinoma using an anti-CLDN6 antibody-drug conjugate Journal:Science Translational Medicine	Kong, FE Li, GM Tang, YQ Xi, SY Loong, JHC Li, MM Li, HL Cheng, W Zhu, WJ Mo, JQ Gong, YF Tang, H Zhao, Y Zhang, Y Ma, S Guan, XY Ma, NF Xie, MB Liu, M	2021	129

Showing results 1 to 5 of 5